
Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 0.47
- High
- PLN 0.47
- Low
- PLN 0.47
- Volume
- 1.3K
- Avg. vol.
- 417.4
- Market cap
- PLN 19.43M
- P/E ratio
- —
- EPS
- -PLN 0.02
- Shares outstanding
- 41.34M
- 52-week
- PLN 0.47 – 0.51
- Dividend yield
- —
- Dividend
- —
- Ex dividend date
- —
- ISIN
- PLSTCLS00013
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 4.86k | USD -41.60k | USD -41.60k |
| Q1 2026 | USD 1.89k | USD -45.11k | USD -45.11k |
| Q4 2025 | USD 8.29k | USD -36.41k | USD -36.41k |
| Q3 2025 | USD 6.28k | USD -29.13k | USD -29.38k |
Results for Q3 2026:Nov 16, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2009-04-08. Active
66 1240 6768 1111 0010 5433 1672
59 1240 6768 1111 0010 4049 9889
98 1240 6768 1111 0010 4030 0143
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
10 public aid cases recorded, with a total value of $556,898.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 16, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | — | Marszałek Województwa Dolnośląskiego | |
| Mar 17, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | — | Marszałek Województwa Dolnośląskiego | |
| Mar 15, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | — | Marszałek Województwa Dolnośląskiego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-11-29 | Opracowanie hydrożelu z zawartością homogenatu porożogennych komórek macierzystych o działaniu neuroprotekcyjnym dla tkanki rdzenia kręgowego | $510,786 | Regionalny Program Operacyjny Województwa Dolnośląskiego 2014-2020 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
One member of the management board is authorized to submit declarations of will on behalf of the company and to represent it in the case of a one-person management board, or two members of the management board jointly or a member of the management board jointly with a commercial proxy in the case of a multi-member management board.
Supervisory board
Beneficial owners
No beneficial owners recorded for the company Stem Cells Spin.
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | |
| Biomarsp. z o.o. | $909,113.28 | biomar.pl | |
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $893,738.50 | lekinatury.pl | |
| Human BiomeS.A. | $888,361.19 | human-biome.com | |
| Zeptor Polskasp. z o.o. | $748,374.79 | zeptor.pl | |
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | |
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com | |
| LideoS.A. | $95,067.91 | lideo.tech | |
| Munar PharmaS.A. | $85,649.72 | munar.pl | |
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl |
Change history
| Date | Event |
|---|---|
| 2026-09-17 | Share capital change (4,133,650.00 PLN → 7,833,650.00 PLN) |
| 2018-07-23 | Share capital change (1,293,650.00 PLN → 4,133,650.00 PLN) |
| 2015-04-23 | PKD change (Added: 46.46.Z, 47.73.Z, 47.74.Z, 47.75.Z, 70.22.Z, 71.20.B, 72.11.Z) |
| 2015-03-10 | PKD change (Removed: 46.46.Z, 47.73.Z, 47.74.Z, 47.75.Z, 64.19.Z, 64.20.Z, 64.99.Z, 69.20.Z, 70.10.Z, 70.22.Z, 71.20.A, 71.20.B, 72.11.Z, 72.19.Z, 73.20.Z, 74.10.Z, 74.30.Z, 74.90.Z, 75.00.Z, 85.59.B, 86.90.E) |
| 2014-01-13 | Share capital change (1,143,650.00 PLN → 1,293,650.00 PLN) |
FAQ
Last updated: 2026-09-17